HCQ for COVID-19
1st treatment shown to reduce risk in
March 2020, now with p < 0.0000000001 from 426 studies, used in 59 countries.
No treatment is 100% effective.
Protocols combine treatments.
HCQ under clinical trials in >10 hospitals in China and has shown fairly good efficacy.
Sun et al., 17 Feb 2020, preprint, 1 author.
